Effects of Insulin Replacements, Inhibitors of Angiotensin, and PKCβ's Actions to Normalize Cardiac Gene Expression and Fuel Metabolism in Diabetic Rats
Emi Arikawa(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Rong Tian(Nanjing University of Chinese Medicine), Zhiheng He(University of Southern California), Ivan Luptak(Boston University), Yasuhiro Maeno, Mary‐Elizabeth Patti(Joslin Diabetes Center), Robert A. Harris(Karolinska University Hospital), Victor A. Zammit(University of Malta), Gordon C. Weir(Joslin Diabetes Center), Ronald C.W.(Chinese University of Hong Kong), Yutaka Yasuda(Joslin Diabetes Center), Keiji Isshiki(Shiga University of Medical Science)
Cited by 51
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k